ZnSe Quantum Dot Sensors for Toxicity-Free Biomolecule Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biodetection methods face limitations such as insufficient sensitivity, complexity, lengthy data collection, lack of selectivity, requirement for specialized equipment, high costs, and toxicity concerns with Cd-containing quantum dots, necessitating the development of more efficient and cost-effective sensors for biological material detection.
Innovation Solution
The use of semiconductor nanocrystal-based optical sensors, specifically ZnSe quantum dots with organic bi-functional molecules, allows for direct, rapid, and accurate detection of biomolecules by monitoring changes in fluorescence emission spectra upon binding with target biological materials without the need for additional fluorophores, enabling multiplexed and homogeneous assays.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Illumination intensity
If Cd-containing quantum dots are used for biodetection, then fluorescence emission intensity and quantum yield are improved, but toxicity increases limiting in vivo applications
Solution Approach 1:
The patent extracts and removes the toxic cadmium component from the quantum dot structure, replacing it with cadmium-free semiconductor materials such as ZnSe, ZnS, or InP while maintaining the core-shell architecture. This extraction eliminates the harmful Cd2+ ions that leach into the biological environment, thereby resolving the toxicity issue while preserving the fluorescent properties through careful material selection and structural design.
Solution Approach 2:
The patent employs composite material structures by combining cadmium-free semiconductor materials with organic bi-functional molecules and biomolecular probes. The core-shell structure integrates different materials with complementary properties: the semiconductor core provides fluorescent emission, while the shell and surface modifications enhance stability, reduce toxicity, and enable specific binding to target biomolecules, thus achieving both low toxicity and high fluorescence intensity.
2Reliability
If traditional fluorophore labels are used, then detection capability is achieved, but sensitivity and selectivity are insufficient
Solution Approach 1:
The patent exploits the size-dependent optical properties of quantum dots by precisely controlling their size (2-50 nm range) to tune emission wavelengths and enhance fluorescence intensity. This parameter control allows optimization of detection sensitivity and selectivity, as smaller QDs exhibit higher surface area to volume ratios and enhanced quantum confinement effects, leading to improved detection capabilities compared to traditional fluorophores.
3Measurement precision
If complex detection systems are used, then detection accuracy is improved, but system complexity and operational complexity increase
Solution Approach 1:
The patent merges multiple functions into a single quantum dot probe structure: the semiconductor core provides fluorescence for detection, the shell provides stability and protection, and surface-modified biomolecular probes provide specific binding to targets. This integration eliminates the need for separate labeling steps and complex multi-component systems, simplifying the overall detection process while maintaining high accuracy through the inherent properties of the quantum dot structure.
Solution Approach 2:
The quantum dot-based sensors enable direct detection where the quantum dots themselves serve as both the fluorescent label and the detection probe. The biomolecular probes attached to the QD surface provide specific recognition of target molecules, eliminating the need for additional detection reagents or complex assay procedures, thereby reducing operational complexity while maintaining detection accuracy.
4Reliability
If conventional biodetection methods are used, then detection is achieved, but data collection time and analysis time are lengthy
Solution Approach 1:
The patent enables continuous real-time monitoring of biomolecular interactions by using the intrinsic fluorescence of quantum dots as a continuous signal source. The quantum dots maintain stable fluorescence emission over extended periods without photobleaching, allowing continuous data collection and real-time analysis of binding kinetics and molecular interactions, thereby eliminating the need for discrete sampling and lengthy analysis periods required by conventional methods.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides sensitive, rapid, and cost-effective detection of biomolecules with improved selectivity and specificity, suitable for applications in diagnostics and biological imaging, while avoiding the toxicity issues associated with Cd-containing nanocrystals.
Implementation Method 1
Fluorescent labels emit light upon excitation by an external energy source. Semiconductor nanocrystals, known as Quantum Dots (or QDs), have emerged over the past twenty years as an interesting class of nanomaterials with optical properties
Data Source
AI summary
The invention generally relates to detection and analysis of biological materials. In particular; the invention relates to quantum dot-based optical, sensors and methods for rapid detection and quantitative analysis of various biomolecules and biological materials, such as nucleic acids, proteins, cells, etc.